Paranoid Schizophrenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-08-21
Clinical Trial Update: MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) [Phase 2]
Completed Phase 2 clinical trial of MK0557 for cognitive impairment in schizophrenia, including paranoid schizophrenia, sponsored by Merck S…